Therapy News and Research

RSS

Varying treatment of asthma

Asthma symptoms vary greatly among individuals and vary at times with each individual.

10 Apr 2007

New target for diagnosis and treatment of ovarian cancer

An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.

10 Apr 2007

PSA doubling time and indicator of recurrent prostate cancer

A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy.

10 Apr 2007

Religion has a significant influence on patients' health

More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Apr 2007

Parents well poised to help children overcome bulimia nervosa

Common practice in the treatment of adolescent eating disorder patients has been to exclude the parents. Many experts consider parents part of the problem and thus keep them away during therapy.

10 Apr 2007

FASgen awarded grant for refinement of its serum fatty acid synthase

FASgen has announced that it has been awarded an SBIR grant from National Cancer Institute for refinement of its serum FAS (fatty acid synthase) ELISA cancer diagnostic test, FAS- Detect ELISA.

10 Apr 2007

If you love it eat it! because chocolate helps keep high blood pressure down!

Chocolate, in particular the cocoa-rich dark variety is in the news again because of it's apparent health benefits.

10 Apr 2007

HRT scare questioned

According to the latest research hormone replacement therapy (HRT) may not be quite as dangerous as was first implied by a major American study in 2002.

8 Apr 2007

Newborn screening programmes for cystic fibrosis should be adopted internationally

Newborn screening for cystic fibrosis saves on treatment costs and would offset the actual costs of the screening programme.

8 Apr 2007

Hope for victims of eating disorders in Britain

They say anorexia is the biggest killer of any psychiatric disorder; Department of Health, figures show as many as 15% of cases result in death.

8 Apr 2007

Weak immune response critical to disease that causes most infant hospitalizations

The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two.

7 Apr 2007

Scientists link treatment-induced growth factor to cancer spread

In advanced cancer, anti-tumor therapies often work only partially or not at all, and tumors progress following treatment.

7 Apr 2007

TGF-beta inhibitors stop tumors spreading to new sites

For several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis.

7 Apr 2007

Stem cells offer new ways of treating hearing loss

Have you ever walked by someone listening to their i-Pod loud enough for you recognize the song? Studies have shown noise-induced hearing loss is going to become the next big epidemic affecting our younger generation though the effects won't show until it is too late to treat.

7 Apr 2007

Largest-ever Parkinson's disease trials

Researchers with the National Institute of Neurological Disorders and Stroke (NINDS) have initiated one of the largest-ever Parkinson's disease clinical trials.

7 Apr 2007

Eslicarbazepine shows promise for treating epileptic seizures

A new study appearing in the latest issue of Epilepsia shows that a new drug called Eslicarbazepine (ESL) shows promise as a treatment for epilepsy patients whose symptoms remain uncontrolled with existing medications.

7 Apr 2007

Alteon expands agreement with Biorap Technologies

Alteon has announced that it has entered into an expanded licensing agreement with BioRap Technologies, the commercialization arm of the Rappaport Family Institute for Research, Technion University, Israel, for all diagnostic devices or products for predictive purposes in vascular or cardiac diseases, including diagnostic assays for the measurement of the haptoglobin protein (Hp).

7 Apr 2007

Lower doses of dexamethasone for multiple myeloma recommended

The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.

5 Apr 2007

Pharmacyclics undergoes 'file over protest' for Xcytrin NDA

Pharmacyclics, Inc. has announced its request to the U.S. Food and Drug Administration (FDA) that its New Drug Application (NDA) for Xcytrin (motexafin gadolinium) Injection be filed over protest.

5 Apr 2007

Newmarket, Ontario to establish world-class cancer centre

Princess Margaret Hospital (PMH) will share its latest knowledge, research in cancer care, and expertise to assist Southlake Regional Health Centre (Southlake) in establishing a world-class cancer centre through a formal affiliation between a world leader in cancer care and the newly established cancer program in the Newmarket-based hospital.

5 Apr 2007